72.19.Z - Other research and experimental development on natural sciences and engineering
21.20.Z - Manufacture of medicines and other pharmaceutical products
32.50.Z - Manufacture of medical and dental instruments and supplies
49.41.Z - Freight transport by road
72.11.Z - Research and experimental development on biotechnology
85.59.B - Other out-of-school forms of education, not elsewhere classified
86.10.Z - Hospital activities
86.90.B - Emergency ambulance activities
86.90.E - Other human health activities notelsewhere classified
96.03.Z - Funeral and related activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0 | 0,8 | -0 | -104,2 |
Gross profit (loss) | -0 | 0,8 | -0 | -106,1 |
EBITDA | -0 | 0,8 | -0 | -106 |
Short time liabilities | 0 | 0 | 0,1 | 104,4 |
Other operating costs | 0 | 0 | 0 | -∞ |
Equity capital | 0,5 | 1,2 | 1,2 | -2,3 |
Operating profit (EBIT) | -0 | 0,8 | -0 | -106 |
Assets | 0,5 | 1,3 | 1,3 | 1,4 |
Net profit (loss) | -0 | 0,7 | -0 | -106,6 |
Cash | 0,5 | 1,2 | 1,2 | 3,7 |
Liabilities and provisions for liabilities | 0 | 0 | 0,1 | 104,4 |
Net income from sale | 0 | 2,9 | 0,2 | -94,6 |
Working assets | 0,5 | 1,3 | 1,3 | 1,4 |
Other income costs | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -1 | 60,6 | -4,1 | -64,7 |
Equity capital to total assets | 98,8 | 96,5 | 92,9 | -3,6 |
Gross profit margin | -161,4 | 28,2 | -31,5 | -59,7 |
EBITDA Margin | -161,4 | 28,2 | -31 | -59,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 707 | 6 | 212 | 206 |
Current financial liquidity indicator | 82.72652435302734 | 28.402559280395508 | 14.090373992919922 | -14,3 |
Net dept to EBITDA | 98.71375274658203 | -1.46689772605896 | 25.4489803314209 | 26,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane